000			01335 a2200325 4500
005			20250516020555.0
264		0	_c20110617
008			201106s 0 0 eng d
022			_a1090-2430
024	7		_a10.1016/j.expneurol.2010.12.022 _2doi
040			_aNLM _beng _cNLM
100	1		_aBarkhoudarian, Melita T
245	0	0	_aPreclinical jockeying on the translational track of adenosine A2A receptors. _h[electronic resource]
260			_bExperimental neurology _cApr 2011
300			_a160-4 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Review; Comment
650	0	4	_aAdenosine A2 Receptor Antagonists _xtherapeutic use
650	0	4	_aAnimals
650	0	4	_aClinical Trials as Topic _xtrends
650	0	4	_aDisease Models, Animal
650	0	4	_aDrug Delivery Systems _xtrends
650	0	4	_aDrug Evaluation, Preclinical _xtrends
650	0	4	_aHumans
650	0	4	_aParkinsonian Disorders _xdrug therapy
650	0	4	_aReceptor, Adenosine A2A _xmetabolism
650	0	4	_aTranslational Research, Biomedical _xtrends
700	1		_aSchwarzschild, Michael A
773	0		_tExperimental neurology _gvol. 228 _gno. 2 _gp. 160-4
856	4	0	_uhttps://doi.org/10.1016/j.expneurol.2010.12.022 _zAvailable from publisher's website
999			_c20496722 _d20496722